Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2024, Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment., Haemophilia
et al., 2024, Diagnosis and management of heparin-induced thrombocytopenia: Third edition., Br J Haematol, Vol:204, Pages:459-475
et al., 2024, Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel., Haemophilia
et al., 2023, Multiple myeloma and its treatment contribute to increased platelet reactivity, Platelets, Vol:34, ISSN:0953-7104
et al., 2023, Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK, Journal of Thrombosis and Haemostasis, Vol:21, ISSN:1538-7836, Pages:2735-2746